Dibi · Xarxa de diagnòstic biomèdic i per la imatge

What Dibi · Xarxa de diagnòstic biomèdic i per la imatge does

Dibi is a public network of integrated biomedical and imaging diagnostic services operating across Catalonia, Spain. The network brings together three diagnostic disciplines — clinical analyses, anatomical pathology, and diagnostic imaging and nuclear medicine — under a single coordinated structure, serving public hospitals and health centers. It is operated by two publicly owned entities: Laboratori de Referència de Catalunya (LRC, founded 1992) and Imatge Mèdica Intercentres (IMI, founded 2009), with Hospital del Mar's anatomical pathology service contributing the third diagnostic area. Governance is held by public healthcare bodies, with the Consorci de Salut i Social de Catalunya controlling 49% of LRC and Hospital del Mar controlling 51% of IMI.

The platform manages 14 clinical analysis laboratories deployed across public hospitals in Catalonia, with an ongoing multi-year modernization program upgrading biochemistry, immunochemistry, urinalysis, and immunohematology equipment. Technical capabilities span radiography, CT, MRI (1.5T and 3 Tesla), ultrasound with contrast, digital mammography with tomosynthesis, interventional radiology, SPECT scintigraphy, and PET-CT, augmented by 3D segmentation and augmented reality tools for surgical planning. Stated AI, deep learning, and big data capabilities support diagnostic interpretation and personalized medicine initiatives, though proprietary AI assets are not publicly documented. Dibi's member network includes 16+ institutions such as Hospital del Mar, Consorci Sanitari del Maresme, Clínica Terres de l'Ebre, Fundació Pasqual Maragall, and Espitau Val d'Aran.

Revenue is generated through public healthcare contracts and inter-hospital diagnostic service arrangements within the Catalan public healthcare system. The organization does not have external private investors and operates as a non-commercial public network. Dibi currently employs approximately 35 staff and is headquartered in El Prat de Llobregat, Barcelona, with GDPR-compliant data governance and an appointed Data Protection Officer.

Name

Dibi · Xarxa de diagnòstic biomèdic i per la imatge

Legal name

LABORATORI DE REFERÈNCIA DE CATALUNYA, SA

Website

https://dibi.cat

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

Dibi is a Catalan public network integrating clinical analyses, anatomical pathology, and diagnostic imaging and nuclear medicine across 14 laboratories and 16+ member public hospitals and health centers in Catalonia, Spain, operated through LRC and IMI.

Ownership category

akta.pro rank

Headquarters

HQ city

El Prat de Llobregat

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Public Healthcare Diagnostic Services: As a public network of integrated diagnostic services, Dibi provides services to hospitals and health centers in Catalonia through public healthcare contracts and partnerships. Revenue is generated through the provision of clinical analyses, anatomical pathology, and diagnostic imaging services to public healthcare institutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Dibi is a public network of integrated biomedical and imaging diagnostic services targeting hospitals and health centers in Catalonia. The network delivers three interconnected diagnostic areas — clinical analyses, anatomical pathology, and diagnostic imaging & nuclear medicine — coordinated through 14 clinical laboratories across public hospitals and supported by AI, deep learning, and big data for diagnostic interpretation and personalized medicine.

Product overview

Dibi is a public network of integrated biomedical and imaging diagnostic services for hospitals and healthcare centers in Catalonia. The offering is structured around three interconnected diagnostic areas: Clinical Analysis (biochemistry, hematology, immunology, microbiology, molecular biology), Pathological Anatomy (cytology, biopsies, surgical pathology, cytogenetics, molecular biology), and Diagnostic Imaging & Nuclear Medicine (radiography, CT, MRI, ultrasound, mammography, interventional radiology, nuclear medicine). These services are delivered through a network of 16 public hospitals and healthcare centers, managed by Laboratori de Referència de Catalunya (LRC) and Imatge Mèdica Intercentres (IMI). Advanced technologies including AI, deep learning, and big data support diagnostic interpretation and integration for personalized medicine. The network manages 14 clinical analysis laboratories across Catalonia's public hospitals.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Analysis Services (Anàlisis clíniques)

Quantifiable outcome

• Significant improvement in precision and accuracy of determinations with new biochemistry and immunochemistry equipment
• +2 more outcomes

Named customers15 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Imatge Mèdica Intercentres (IMI)coreStrategic or Co-development Partner · 1 January 2009IMI was founded in 2009 to provide radiological and nuclear medicine tests and support healthcare professionals. Since its origins, it has handled diagnostic imaging and nuclear medicine for Hospital del Mar, and serves as a core driver of the Dibi network alongside LRC.
• Laboratori de Referència de Catalunya (LRC)coreStrategic or Co-development Partner · 1 January 1992LRC was established in 1992 to offer clinical analysis services and advise healthcare professionals on clinical, diagnostic, and therapeutic decisions. It is currently one of the main laboratory networks in Catalonia and serves as the primary driver of the Dibi network alongside IMI.
• Hospital del MarcoreStrategic or Co-development PartnerHospital del Mar contributes the anatomical pathology service to the Dibi network, providing the third diagnostic area. It has one of the most powerful and developed anatomical pathology departments in Catalonia.
• Consorci de Salut i Social de CatalunyacoreStrategic or Co-development PartnerMajor shareholder (49%) of Laboratori de Referència de Catalunya, SA, contributing to the governance of the Dibi network.
• Sub-direcció General de Vigilància i Resposta a Emergències de Salut PúblicaminorStrategic or Co-development PartnerGovernment body that sponsored the study on invasive Streptococcus pyogenes infections in Catalonia, collaborating with Dibi's Microbiology Service professionals.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Quest Diagnostics: One of the world's largest clinical laboratory and diagnostic information services providers. Comparable to Dibi at the category level (clinical diagnostics, pathology, hospital-focused services) though far broader in geographic and product scope.
• Labcorp: Global clinical laboratory and diagnostics network offering routine and esoteric testing plus drug development services. Operates in the same broad diagnostic-services space as Dibi and serves hospital systems, but at much larger scale and geographic reach.
• Eurofins Scientific: Global testing services group with substantial clinical diagnostics operations across Europe. Comparable to Dibi in clinical-analysis scope and European footprint, though Eurofins operates across food, environment, and pharma testing as well.

Regional players

• Institut Català de la Salut (ICS): Public healthcare provider operating the majority of public hospitals and primary care centers in Catalonia. A key counterpart and potential customer/partner of Dibi, sharing the same regional public-health ecosystem.
• Hospital de la Santa Creu i Sant Pau: Major Barcelona university hospital with its own diagnostic and pathology services. Comparable to Dibi as a high-complexity Catalan public hospital operating in the same diagnostic-services space, though primarily as a single institution rather than a network.

Direct peers

• Synlab: Europe's largest medical diagnostics services provider, operating reference labs and hospital-linked diagnostic services across multiple countries. Directly comparable to Dibi as a clinical-analysis and diagnostic-imaging services platform serving public and private healthcare providers.
• Echevarne: Spanish clinical analysis laboratory network operating across multiple regions, serving hospitals and primary care. Directly comparable to Dibi in the Spanish clinical-analysis and hospital-services segment.
• Cerba Healthcare: European network of reference laboratories and diagnostic centers serving hospitals and clinics. Comparable to Dibi as a multi-site clinical-diagnostics operator focused on specialty testing and hospital partnerships.
• Reference Laboratory: Spain-based clinical reference laboratory providing specialized testing services to hospitals, clinics, and healthcare professionals. Closely comparable to LRC's role within Dibi in serving Catalan and Spanish hospital networks.
• Unilabs: Major European diagnostic services group offering clinical laboratory, pathology, and imaging services to hospitals and clinicians. Closely comparable to Dibi in its multi-pillar diagnostic offering and hospital-customer base, with a presence in Spain.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/dibixarxa
• YouTubeyoutube.com/channel/UCxmgQW5wtFIt97ZUSEzDWLA
• LinkedInlinkedin.com/company/dibixarxa

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dibi · Xarxa de diagnòstic biomèdic i per la imatge